Clinical Trial Update: Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects [Phase 1]

View source ↗

Summary

A Phase 1 randomized, double-blind, placebo-controlled study of RSS0393 ointment in healthy and psoriatic subjects is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• RSS0393 Ointment

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Healthy, Psoriatic Subjects | Phase 1 | Status: ACTIVE_NOT_RECRUITING